Open, Prospective, Historic-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Infusion of Liver Cell Suspension (HHLivC) in Children With Urea Cycle Disorders

Trial Profile

Open, Prospective, Historic-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Infusion of Liver Cell Suspension (HHLivC) in Children With Urea Cycle Disorders

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Liver cell therapy (Primary)
  • Indications Inborn urea cycle disorders
  • Focus Therapeutic Use
  • Acronyms SELICA III
  • Sponsors Cytonet; Promethera Biosciences
  • Most Recent Events

    • 05 Feb 2016 Status changed from recruiting to discontinued as reported by cliinicaltrials.gov record.
    • 09 Dec 2014 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 according to cliinicaltrials.gov record.
    • 09 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 according to cliinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top